Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP-325 in Type 2 Diabetes
NCT05160272Phase 2Completed
- Sponsor
- German Diabetes Center
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AP-325 in type 2 diabetes mellitus (T2DM), sponsored by German Diabetes Center. Started Jan 2022; status: completed.
02
Drugs
AP-325
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05160272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160272.